Federated Hermes’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.18M Buy
514,656
+29,278
+6% +$181K 0.01% 876
2025
Q4
$3.26M Buy
485,378
+58,514
+14% +$439K 0.01% 862
2025
Q3
$3.49M Buy
426,864
+3,544
+0.8% +$26.5K 0.01% 809
2025
Q2
$2.98M Buy
423,320
+18,425
+5% +$124K 0.01% 848
2025
Q1
$2.89M Buy
404,895
+622
+0.2% +$5.87K 0.01% 849
2024
Q4
$3.71M Buy
404,273
+58,257
+17% +$545K 0.01% 785
2024
Q3
$3.36M Buy
346,016
+1,334
+0.4% +$14K 0.01% 816
2024
Q2
$2.8M Sell
344,682
-63
-0% -$488 0.01% 847
2024
Q1
$2.78M Buy
344,745
+79,260
+30% +$561K 0.01% 853
2023
Q4
$1.46M Buy
265,485
+206,125
+347% +$1.09M ﹤0.01% 1028
2023
Q3
$310K Sell
59,360
-11,098
-16% -$78.9K ﹤0.01% 1456
2023
Q2
$814K Sell
70,458
-350,917
-83% -$4.14M ﹤0.01% 1206
2023
Q1
$5.26M Sell
421,375
-30,482
-7% -$584K 0.01% 679
2022
Q4
$8.91M Sell
451,857
-190,296
-30% -$4.1M 0.02% 571
2022
Q3
$15.6M Buy
642,153
+42,340
+7% +$1.17M 0.05% 437
2022
Q2
$14.5M Buy
599,813
+365,311
+156% +$9.71M 0.04% 461
2022
Q1
$7.6M Buy
234,502
+221,991
+1,774% +$6.98M 0.02% 675
2021
Q4
$425K Sell
12,511
-173
-1% -$6.29K ﹤0.01% 1522
2021
Q3
$547K Sell
12,684
-74,109
-85% -$4.56M ﹤0.01% 1489
2021
Q2
$5.66M Buy
86,793
+61,711
+246% +$3.91M 0.01% 808
2021
Q1
$1.32M Sell
25,082
-29,573
-54% -$1.48M ﹤0.01% 1267
2020
Q4
$2.44M Sell
54,655
-136,567
-71% -$4.72M 0.01% 993
2020
Q3
$5.54M Buy
191,222
+41,210
+27% +$1.29M 0.01% 708
2020
Q2
$5.33M Buy
150,012
+148,224
+8,290% +$6.25M 0.01% 699
2020
Q1
$92K Sell
1,788
-371,638
-100% -$17.9M ﹤0.01% 1657
2019
Q4
$25.5M Sell
373,426
-107,335
-22% -$6.73M 0.06% 351
2019
Q3
$23M Buy
480,761
+258,632
+116% +$13.5M 0.06% 332
2019
Q2
$14.8M Buy
222,129
+215,364
+3,184% +$16.4M 0.04% 443
2019
Q1
$646K Sell
6,765
-1,220
-15% -$152K ﹤0.01% 1404
2018
Q4
$992K Sell
7,985
-82,673
-91% -$13.6M ﹤0.01% 1288
2018
Q3
$22.1M Buy
90,658
+6,475
+8% +$1.5M 0.05% 332
2018
Q2
$15.7M Sell
84,183
-14,523
-15% -$2.42M 0.05% 319
2018
Q1
$12.1M Buy
98,706
+14,667
+17% +$1.79M 0.04% 376
2017
Q4
$10M Buy
84,039
+48,929
+139% +$5.39M 0.03% 433
2017
Q3
$3.34M Buy
35,110
+23,250
+196% +$2.24M 0.01% 707
2017
Q2
$1.13M Sell
11,860
-896
-7% -$76.6K ﹤0.01% 1158
2017
Q1
$989K Buy
12,756
+3,419
+37% +$237K ﹤0.01% 1176
2016
Q4
$627K Sell
9,337
-4,691
-33% -$289K ﹤0.01% 1256
2016
Q3
$840K Buy
14,028
+5,376
+62% +$300K ﹤0.01% 1146
2016
Q2
$434K Sell
8,652
-8,249
-49% -$393K ﹤0.01% 1314
2016
Q1
$760K Sell
16,901
-3,022
-15% -$108K ﹤0.01% 1164
2015
Q4
$799K Sell
19,923
-14,035
-41% -$593K ﹤0.01% 1169
2015
Q3
$1.65M Buy
33,958
+6,355
+23% +$302K 0.01% 937
2015
Q2
$1.23M Buy
27,603
+27,404
+13,771% +$1.05M ﹤0.01% 1086
2015
Q1
$6K Sell
199
-53
-21% -$1.71K ﹤0.01% 1836
2014
Q4
$8K Hold
252
﹤0.01% 1768
2014
Q3
$5K Buy
+252
New +$5.12K ﹤0.01% 1839

Other funds holding INGN

Federated Hermes's INGN Position: Q1 2026 in Review

Federated Hermes increased its Inogen (INGN) stake by 6% in Q1 2026, buying an estimated $181K and bringing the position to 514,656 shares worth $3.18M. The position accounts for 0.01% of the portfolio, ranked #876.

Federated Hermes first reported a position in INGN in Q3 2014 and has held it in 47 quarters since. The position peaked at $25.5M in Q4 2019. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.

  • Federated Hermes held 514,656 shares of Inogen worth $3.18M as of Q1 2026.
  • Federated Hermes bought 29,278 Inogen shares in Q1 2026, an estimated $181K.
  • Inogen made up 0.01% of Federated Hermes's portfolio in Q1 2026, its #876 holding.
  • Federated Hermes first reported a position in Inogen in Q3 2014 and has held it in 47 quarters since.
  • Federated Hermes's Inogen position peaked at $25.5M in Q4 2019.
  • 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.